Highlights from ACR Convergence 2022
In this episode of Meeting Mic, we bring you the highlights and insights from the ACR Convergence 2022, as well as Healio’s top headlines from the meeting.
Alfred Kim, MD, discusses some key take-home points from the Long COVID presentation :18
Giovanni Adami, MD, reviews the impact of tofacitinib on fracture risk in patients with rheumatoid arthritis and the effect of glucocorticoids on bone density. 3:39
Leonard Calabrese, DO, gives a long-view of the meeting and the sessions he attended. 6:06
Paul Emery, MD, discusses results of a phase 2 study of peresolimab for adults with rheumatoid arthritis. 9:32
Read the full coverage here:
ACR: Varicella vaccine strongly recommended in all immunosuppressed adults
‘Anatomy inventory’ fosters more inclusive care for transgender, non-binary patients
'Strange times’: Prescribing methotrexate legally ‘low risk’ Post-Roe
Collapse
